Attenuation of Nitrogen Mustard-Induced Pulmonary Injury and Fibrosis by Anti-Tumor Necrosis Factor-α Antibody

被引:50
|
作者
Malaviya, Rama [1 ]
Sunil, Vasanthi R. [1 ]
Venosa, Alessandro [1 ]
Verissimo, Vivianne L. [1 ]
Cervelli, Jessica A. [1 ]
Vayas, Kinal N. [1 ]
Hall, LeRoy [3 ]
Laskin, Jeffrey D. [2 ]
Laskin, Debra L. [1 ]
机构
[1] Rutgers State Univ, Dept Pharmacol & Toxicol, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Dept Environm & Occupat Med, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA
[3] Janssen Res & Dev, Dept Drug Safety Sci, Raritan, NJ 08869 USA
基金
美国国家卫生研究院;
关键词
alveolar macrophages; lung injury; vesicant; fibrosis; ACUTE LUNG INJURY; SULFUR MUSTARD; MACROPHAGE ACTIVATION; TISSUE-INJURY; MURINE MODEL; TNF-ALPHA; INFLAMMATION; EXPRESSION; MECHANISMS; RECEPTOR;
D O I
10.1093/toxsci/kfv161
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Nitrogen mustard (NM) is a bifunctional alkylating agent that causes acute injury to the lung that progresses to fibrosis. This is accompanied by a prominent infiltration of macrophages into the lung and upregulation of proinflammatory/profibrotic cytokines including tumor necrosis factor (TNF)alpha. In these studies, we analyzed the ability of anti-TNF alpha antibody to mitigate NM-induced lung injury, inflammation, and fibrosis. Treatment of rats with anti-TNF alpha antibody (15 mg/kg, iv, every 9 days) beginning 30 min after intratracheal administration of NM (0.125 mg/kg) reduced progressive histopathologic alterations in the lung including perivascular and peribronchial edema, macrophage/monocyte infiltration, interstitial thickening, bronchiolization of alveolar walls, fibrin deposition, emphysema, and fibrosis. NM-induced damage to the alveolar-epithelial barrier, measured by bronchoalveolar lavage (BAL) protein and cell content, was also reduced by anti-TNF alpha antibody, along with expression of the oxidative stress marker, heme oxygenase-1. Whereas the accumulation of proinflammatory/cytotoxic M1 macrophages in the lung in response to NM was suppressed by anti-TNF alpha antibody, antiinflammatory/profibrotic M2 macrophages were increased or unchanged. Treatment of rats with anti-TNF alpha antibody also reduced NM-induced increases in expression of the profibrotic mediator, transforming growth factor-beta. This was associated with a reduction in NM-induced collagen deposition in the lung. These data suggest that inhibiting TNF alpha may represent an efficacious approach to mitigating lung injury induced by mustards.
引用
收藏
页码:71 / 88
页数:18
相关论文
共 50 条
  • [21] Tumor necrosis factor-α induced protein 6 attenuates acute lung injury following paraquat exposure
    Xu, Jiajun
    Zhen, Jiantao
    Zhu, Jingfa
    Lin, Qingming
    TOXICOLOGY MECHANISMS AND METHODS, 2016, 26 (01) : 32 - 35
  • [22] Hyperactive neutrophil chemotaxis contributes to anti-tumor necrosis factor-α treatment resistance in inflammatory bowel disease
    Yau, Tung On
    Vadakekolathu, Jayakumar
    Foulds, Gemma Ann
    Du, Guodong
    Dickins, Benjamin
    Polytarchou, Christos
    Rutella, Sergio
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (03) : 531 - 541
  • [23] Rash induced by anti-tumor necrosis factor agents in an adolescent with Crohn's disease
    Conklin, Laurie S.
    Cohen, Bernard
    Wilson, Lindsay
    Cuffari, Carmen
    Oliva-Hemker, Maria
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2010, 7 (03) : 174 - 177
  • [24] On Anti-Tumor Necrosis Factor-induced Systemic Lupus Erythematosus
    Jacob, Noam
    Jacob, Chaim O.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (01) : 3 - 5
  • [25] Effect of anti-tumor necrosis factor-α therapies on body mass index in patients with psoriasis
    Saraceno, Rosita
    Schipani, Caterina
    Mazzotta, Annamaria
    Esposito, Maria
    Di Renzo, Laura
    De Lorenzo, Antonino
    Chimenti, Sergio
    PHARMACOLOGICAL RESEARCH, 2008, 57 (04) : 290 - 295
  • [26] Anti-tumor necrosis factor-α therapy during murine Klebsiella pneumoniae bacteremia:: Increased mortality in the absence of liver injury
    Moore, TA
    Lau, HY
    Cogen, AL
    Monteleon, CL
    Standiford, TJ
    SHOCK, 2003, 20 (04): : 309 - 315
  • [27] Anti-tumor necrosis factor-α blockade improves insulin resistance in patients with rheumatoid arthritis
    Gonzalez-Gay, MA
    De Matias, JM
    Gonzalez-Juanatey, C
    Garcia-Porrua, C
    Sanchez-Andrade, A
    Martin, J
    Llorca, J
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (01) : 83 - 86
  • [28] Anti-tumor necrosis factor-α treatment improves endothelial function in patients with rheumatoid arthritis
    Hürlimann, D
    Forster, A
    Noll, G
    Enseleit, F
    Chenevard, R
    Distler, O
    Béchir, M
    Spieker, LE
    Neidhart, M
    Michel, BA
    Gay, RE
    Lüscher, TF
    Gay, S
    Ruschitzka, F
    CIRCULATION, 2002, 106 (17) : 2184 - 2187
  • [29] The 3′ untranslated region of tumor necrosis factor-α is highly conserved in idiopathic pulmonary fibrosis
    Freeburn, RW
    Kendall, H
    Dobson, L
    Egan, J
    Simler, NJ
    Millar, AB
    EUROPEAN CYTOKINE NETWORK, 2001, 12 (01) : 33 - 38
  • [30] Periodontal Condition of Patients With Autoimnnune Diseases and the Effect of Anti-Tumor Necrosis Factor-α Therapy
    Mayer, Yaniv
    Elimelech, Rina
    Balbir-Gurman, Alexandra
    Braun-Moscovici, Yolanda
    Machtei, Eli E.
    JOURNAL OF PERIODONTOLOGY, 2013, 84 (02) : 136 - 142